KIC
EW icon

Kensington Investment Counsel’s Edwards Lifesciences EW Stock Holding History

Kensington Investment Counsel’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,681
Closed -$1.21M – 110
2024
Q1 		$1.21M Sell
12,681
-6,019
-32% -$506K 0.55% 59
2023
Q4 		$1.43M Sell
18,700
-105
-0.6% -$7.31K 0.75% 50
2023
Q3 		$1.3M Buy
18,805
+153
+0.8% +$12.3K 0.81% 45
2023
Q2 		$1.76M Sell
18,652
-221
-1% -$19.2K 1.12% 33
2023
Q1 		$1.56M Sell
18,873
-1,295
-6% -$102K 1.18% 35
2022
Q4 		$1.5M Sell
20,168
-333
-2% -$25.7K 1.18% 37
2022
Q3 		$1.69M Sell
20,501
-5
-0% -$481 1.43% 29
2022
Q2 		$1.95M Sell
20,506
-455
-2% -$47.1K 1.66% 19
2022
Q1 		$2.47M Sell
20,961
-1,414
-6% -$159K 1.63% 15
2021
Q4 		$2.9M Buy
+22,375
New +$2.61M 1.69% 14
2021
Q2 		$2.15M Buy
20,736
+466
+2% +$43.9K 1.47% 20
2021
Q1 		$1.7M Buy
20,270
+895
+5% +$75.7K 1.27% 32
2020
Q4 		$1.77M Buy
+19,375
New +$1.61M 1.46% 19

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Kensington Investment Counsel's EW Position: Q2 2024 in Review

Kensington Investment Counsel sold out of Edwards Lifesciences (EW) in Q2 2024, closing a stake of 12,681 shares — an estimated $1.21M sold.

Kensington Investment Counsel first reported a position in EW in Q4 2020 and held it in 13 quarters. The position peaked at $2.9M in Q4 2021. 1,296 funds tracked by Wall St. Rank hold EW as of Q2 2024.

  • Kensington Investment Counsel reported no remaining Edwards Lifesciences position as of Q2 2024 after selling out during the quarter.
  • Kensington Investment Counsel sold 12,681 Edwards Lifesciences shares in Q2 2024, an estimated $1.21M.
  • Kensington Investment Counsel first reported a position in Edwards Lifesciences in Q4 2020 and held it in 13 quarters.
  • Kensington Investment Counsel's Edwards Lifesciences position peaked at $2.9M in Q4 2021.
  • 1,296 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2024.

Based on Kensington Investment Counsel's 13F filing for Q2 2024, filed 14 Aug 2024.